129 related articles for article (PubMed ID: 11855679)
41. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery.
von Baum H; Böttcher S; Hoffmann H; Sonntag HG
J Antimicrob Chemother; 2001 May; 47(5):729-30. PubMed ID: 11328803
[No Abstract] [Full Text] [Related]
42. Pharmacokinetic characteristics of the novel anticancer agent CPT-11 and its active metabolite in plasma and lung lymph fluid following intravenous administration to sheep.
Koizumi T; Kubo K; Hanaoka M; Miyahara T; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Sekiguchi M
Arzneimittelforschung; 1998 Nov; 48(11):1097-100. PubMed ID: 9850432
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects.
Zhang L; Li JT; Lu Y; Li MN; Zhang YL; Liu Y; Li TY; Zhang JW
Acta Pharmacol Sin; 2002 Apr; 23(4):381-4. PubMed ID: 11931699
[TBL] [Abstract][Full Text] [Related]
44. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
[TBL] [Abstract][Full Text] [Related]
45. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
[TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
[TBL] [Abstract][Full Text] [Related]
47. Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis.
Chimura T; Arai M; Onuma Y; Oda T; Kawagoe S; Kunii K; Saito T; Saito N; Sato F; Numazaki M; Matsuo M; Murayama K; Morizaki N
Jpn J Antibiot; 1997 Nov; 50(11):871-7. PubMed ID: 9651605
[TBL] [Abstract][Full Text] [Related]
48. The comparative arthropathy of fluoroquinolones in dogs.
Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
[TBL] [Abstract][Full Text] [Related]
49. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
[TBL] [Abstract][Full Text] [Related]
50. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
Sun J; Sakai S; Tauchi Y; Deguchi Y; Chen J; Zhang R; Morimoto K
Eur J Pharm Biopharm; 2002 Jul; 54(1):51-8. PubMed ID: 12084502
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Saux MC; Chassard D; Allaouchiche B
Crit Care Med; 2005 Jan; 33(1):104-9. PubMed ID: 15644655
[TBL] [Abstract][Full Text] [Related]
52. A comparison of fluoroquinolone penetration into human conjunctival tissue.
Aihara M; Miyanaga M; Minami K; Miyata K; Eguchi S; Shiroma H; Sawaguchi S
J Ocul Pharmacol Ther; 2008 Dec; 24(6):587-91. PubMed ID: 19049265
[TBL] [Abstract][Full Text] [Related]
53. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology].
Cho N; Araki H; Kimura T; Shimizu A; Ichikawa K; Fukunaga K; Kunii K
Jpn J Antibiot; 1992 Mar; 45(3):270-84. PubMed ID: 1512924
[TBL] [Abstract][Full Text] [Related]
54. [Fundamental study on levofloxacin in the field of obstetrics and gynecology].
Soyama Y; Mizuhara H; Iwata Y
Jpn J Antibiot; 1992 Mar; 45(3):265-9. PubMed ID: 1512923
[TBL] [Abstract][Full Text] [Related]
55. Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats.
Tanaka M; Takashina H; Tsutsumi S
J Pharm Pharmacol; 2004 Aug; 56(8):977-83. PubMed ID: 15285841
[TBL] [Abstract][Full Text] [Related]
56. Active uptake of ulifloxacin from plasma to lung that controls its concentration in epithelial lining fluid.
Aoki M; Iguchi M; Hayashi H; Shibasaki S; Kurosawa T; Hayashi M
Biol Pharm Bull; 2009 Jun; 32(6):1095-100. PubMed ID: 19483322
[TBL] [Abstract][Full Text] [Related]
57. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.
Capitano B; Mattoes HM; Shore E; O'Brien A; Braman S; Sutherland C; Nicolau DP
Chest; 2004 Mar; 125(3):965-73. PubMed ID: 15006955
[TBL] [Abstract][Full Text] [Related]
58. [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].
Hukagawa H; Noga K
Jpn J Antibiot; 1992 Mar; 45(3):253-7. PubMed ID: 1512921
[TBL] [Abstract][Full Text] [Related]
59. Stereoselective permeation of new fluorinated quinolone derivatives across LLC-PK1 cell monolayers.
Sasaya M; Hatakeyama Y; Saitoh H; Takada M
Biol Pharm Bull; 1999 Jul; 22(7):707-12. PubMed ID: 10443467
[TBL] [Abstract][Full Text] [Related]
60. Levofloxacin pharmacokinetics in children.
Chien S; Wells TG; Blumer JL; Kearns GL; Bradley JS; Bocchini JA; Natarajan J; Maldonado S; Noel GJ
J Clin Pharmacol; 2005 Feb; 45(2):153-60. PubMed ID: 15647407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
